GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.410
-0.090 (-6.00%)
At close: Mar 26, 2026, 4:00 PM EDT
1.460
+0.050 (3.55%)
After-hours: Mar 26, 2026, 7:01 PM EDT

GeoVax Labs Revenue

GeoVax Labs had revenue of $3.35M in the twelve months ending September 30, 2025. In the year 2024, GeoVax Labs had annual revenue of $3.95M.

Revenue (ttm)
$3.35M
Revenue Growth
+8.52%
P/S Ratio
12.64
Revenue / Employee
$197,268
Employees
17
Market Cap
42.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.95M--
Dec 31, 2023---
Dec 31, 202281.53K-303.98K-78.85%
Dec 31, 2021385.50K-1.44M-78.86%
Dec 31, 20201.82M647.76K55.09%
Dec 31, 20191.18M212.69K22.08%
Dec 31, 2018963.20K-112.07K-10.42%
Dec 31, 20171.08M246.35K29.72%
Dec 31, 2016828.92K400.84K93.64%
Dec 31, 2015428.08K-454.88K-51.52%
Dec 31, 2014882.96K-1.53M-63.48%
Dec 31, 20132.42M-239.78K-9.02%
Dec 31, 20122.66M-2.24M-45.77%
Dec 31, 20114.90M-285.37K-5.50%
Dec 31, 20105.19M1.52M41.36%
Dec 31, 20093.67M758.03K26.05%
Dec 31, 20082.91M2.67M1,127.90%
Dec 31, 2007237.00K-615.90K-72.21%
Dec 31, 2006852.91K182.44K27.21%
Dec 31, 2005670.47K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics43.77M
Radiopharm Theranostics10.86M
Nutriband2.28M
Rallybio858.00K
Lisata Therapeutics170.00K
Entera Bio124.00K
Revenue Rankings